CDISC Announces New Additions to Board of Directors for 2014

CDISC is pleased to announce that four highly qualified individuals will add invaluable expertise to the CDISC Board of Directors (BoD) for a three-year term beginning this month (2014—2017).

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Their backgrounds and expertise will enhance the current Board, ensuring that we continue to work toward realizing the CDISC Strategic Goals over the next three years.

Austin, Texas (PRWEB) January 31, 2014

CDISC is pleased to announce that four highly qualified individuals will add invaluable expertise to the CDISC Board of Directors (BoD) for a three-year term beginning this month (2014—2017). Dr. Charles Cooper, Dr. Dipak Kalra, Joyce Sensmeier and Nevine Zariffa each contribute unique skillsets to the BoD that will greatly assist CDISC as it moves forward with its Strategic Goals in 2014. Dr. Pierre-Yves Lastic is now the new Chair to the CDISC Board, and Ms. Paula Brown Stafford continues her service to the BoD as Past Chair. Dr. David Hardison was voted Chair-Elect to the Board, and Dr. Kiyoteru Takenouchi was re-elected to serve on the BoD for a second term. Sincere appreciation goes to Dr. Frank Rockhold, Sue Dubman and Dr. Eliot Siegel, who completed their CDISC Board service in December 2013.

Charles Cooper, M.D., is the Medical Director of Becton Dickinson Diagnostics. Prior to this role, Dr. Cooper served as Deputy Director of the Office of Computational Science at the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA). In addition to his experience as a practicing infectious disease physician, Dr. Cooper has a broad range of FDA regulatory expertise, including master level clinical reviewer, co-creator of the Quantitative Safety Division, member of the FDA Genomics Work Group and leader of efforts to create the Computational Science Center. Dr. Cooper received his B.A. from the University of Virginia in 1989, and his M.D. in 1995 from Georgetown University School of Medicine.

Dipak Kalra, Ph.D., is Professor of Health Informatics and Director of the Centre for Health Informatics and Multi-professional Education (CHIME) at University College London. In addition to this role, Dr. Kalra also holds the positions of Honorary Senior Academic General Practitioner at the Whittington Hospital NHS Trust in London, the President of the European Institute for Health Records (EuroRec) Institute, Director of the openEHR Foundation, Editor-in-Chief of the AMIA Standards Standard, and Consultant and Advisor on semantic interoperability to the European Commission, English National Health Service, Ministry of Health in Singapore and Ministry of Health in the Kingdom of Saudi Arabia.

Joyce Sensmeier, M.S., R.N., is the Vice President of Informatics at the Healthcare Information and Management Systems Society (HIMSS). She has made contributions to enabling health information exchange through standards profiling, testing and harmonization initiatives. Ms. Sensmeier led the advancement of and currently serves as President of Integrating the Healthcare Enterprise (IHE) USA. IHE USA is a regional deployment committee of IHE International, a standards profiling organization, which over the past decade has achieved both national and international adoption of its public domain technical framework. Ms. Sensmeier is a fellow in the American Academy of Nursing, and has led consortia that include industry, government and clinical leaders in efforts to advance widespread adoption of interoperable electronic health records.

Névine Zariffa, M. Math, is Vice President of Biometrics and Information Sciences at AstraZeneca Pharmaceuticals. Prior to this role, she held a number of positions at GlaxoSmithKline Pharmaceuticals across all phases of drug development. Ms. Zariffa is a pharmaceutical executive with 20 years experience across all phases of drug development. She is an expert in statistics, drug development, portfolio-level decisions, regulatory interactions, strategy, innovation, bridging the discovery/development interface, and business development. Ms. Zariffa received her B.S. in Mathematics from McGill University in 1987, and her M. Math from the University of Waterloo in 1988.

“We are honored to have such an excellent group of experienced professionals join the CDISC Board of Directors. Their backgrounds and expertise will enhance the current Board, ensuring that we continue to work toward realizing the CDISC Strategic Goals over the next three years,” said Dr. Pierre-Yves Lastic, current Chair of the CDISC Board of Directors.

Continuing members of the CDISC Board of Directors, in addition to new members mentioned above are: Dr. Pierre-Yves Lastic, Sanofi (Chair); Paula Brown Stafford, Quintiles (Past Chair); Dr. David Hardison, Recombinant by Deloitte (Chair-Elect); Michael Glickman, Computer Network Architects; David Handelsman, SAS; Dr. Rebecca Kush, CDISC; Wayne Kubick, CDISC; Dr. Douglas Peddicord, ACRO; Stephen Pyke, GlaxoSmithKline; John Speakman, NYU Langone Medical Center; and Dr. Kiyoteru Takenouchi, Medical Front Corporation.

ABOUT CDISC
CDISC is a 501(c)(3) global non-profit charitable organization, with over 300 supporting member organizations from across the clinical research and healthcare arenas. Through the efforts of volunteers around the globe, CDISC catalyzes productive collaboration to develop industry-wide data standards enabling the harmonization of clinical data and streamlining research processes from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data. The CDISC standards and innovations can decrease the time and cost of medical research and improve quality, thus contributing to the faster development of safer and more effective medical products and a learning healthcare system. The CDISC Vision is to inform patient care and safety through higher quality medical research.


Contact